Leica Microsystems, world-leading provider of
Total Digital Pathology solutions, and Indica Labs, developing excellence in image analysis for
Digital Pathology, today announce the integration of Indica Labs' advanced image analysis algorithm
portfolio into Leica Microsystems digital pathology solution. Users of the Leica Microsystems
Tissue IA product can now source from Indica Labs, a range of image analysis algorithms, providing
solutions to many diverse tissue-based quantification applications.
Indica Labs' image analysis algorithms for
molecular assay and morphological feature detection and quantification in whole slide images, coupled
with Leica Microsystems' Tissue IA, provides an easy-to-use solution for
complex image analysis problems in Digital Pathology. Leica Microsystems Tissue
IA software is a key component of the Total
Digital Pathology portfolio and enables the analysis of whole slide images at the touch of a button. The
Indica Labs range, including algorithms for neurobiology, toxicological pathology and brightfield ISH,
can now be seamlessly integrated with Leica's Tissue IA, providing a powerful, yet easy-to-use solution
for a broad range of targeted applications.
Furthermore, custom image analysis algorithms
can be developed by Indica Labs to meet users' varied and specific requirements, facilitating
true flexibility in analysis options.
Donal O'Shea, Head of Digital Pathology in
Leica Microsystems says, "Leica Microsystems remains committed to our open and collaborative
approach with third party vendors in the digital pathology market. This collaboration with Indica Labs
provides an additional choice for our Digital Pathology customers in translational research and
biopharma, allowing them to engage with a specialist vendor to seek high end image analysis capability, while
leveraging the underlying power of Leica Microsystems' Digital Pathology solutions."
Indica Labs' image analysis solutions are
developed with a key focus on the end users' requirements, providing meaningful output data for
publications, reports and studies. With particular focus and experience in the pharmaceutical industry,
Indica's analysis solutions "provide a unique complement to the Leica product line." remarks Indica
CEO, Steven Hashagen. "Together we've been able to achieve a truly seamless integration, which
will allow Leica users to access Indica's large portfolio of precision image analysis tools within the
familiar Tissue IA workflow."
While Leica Microsystems will continue to
develop and expand its existing range of Digital Pathology image analysis solutions, including Tissue IA and
the Ariol system, the integration with Indica Labs give additional options to customers, enabling them
to choose the analysis solution that is right for their needs.
About Leica Microsystems
Leica Microsystems is a world leader in
microscopes and scientific instruments. Founded as a family business in the nineteenth century, the
company's history was marked by unparalleled innovation on its way to becoming a global enterprise. Its
historically close cooperation with the scientific community is the key to Leica Microsystems' tradition of
innovation, which draws on users' ideas and creates solutions tailored to their requirements. At
the global level, Leica Microsystems is organized in four divisions, all of which are among the leaders
in their respective fields: the Life Science Division, Industry Division, Biosystems Division and
Medical Division.
Leica Microsystems' Biosystems Division, also
known as Leica Biosystems, offers histopathology laboratories the most extensive product range
with appropriate products for each work step in histology and for a high level of productivity
in the working processes of the entire laboratory. The company is represented in over 100 countries
with 12 manufacturing facilities in 7 countries, sales
and service organizations in 19 countries and
an international network of dealers. The company is headquartered in Wetzlar, Germany.
About Indica Labs
Indica Labs is the first company to offer
tissue specific and application specific image analysis algorithms in a truly integrated digital
pathology environment. Pharmaceutical, healthcare, and research organizations worldwide utilize
Indica tools for high-throughput, whole-slide image quantification in areas such as neuroscience,
metabolism, oncology, toxicological pathology, and more.